Nicholas Augustinos - 08 May 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Nicholas Augustinos
Issuer symbol
DXCM
Transactions as of
08 May 2025
Net transactions value
$0
Form type
4
Filing time
12 May 2025, 16:08:15 UTC
Previous filing
24 May 2024
Next filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AUGUSTINOS NICHOLAS Director 6340 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Nicholas Augustinos 12 May 2025 0001238485

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Gift $0 -2,618 -100% $0.000000 0 08 May 2025 Direct F1
transaction DXCM Common Stock Gift $0 +2,618 +7.1% $0.000000 39,701 08 May 2025 by Trust F1, F2
transaction DXCM Common Stock Award $0 +5,046 $0.000000 5,046 08 May 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.
F2 Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is trustee.
F3 The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.